Skip to content

Therapies for dactylitis in psoriatic arthritis. A systematic review

by Helliwell P.S.
Journal of Rheumatology ()

Abstract

Dactylitis is a hallmark clinical feature of psoriatic arthritis (PsA). Acute dactylitis appears to be a severity marker for PsA and psoriasis. Traditionally, clinicians have used nonsteroidal antiinflammatory rheumatic drugs and local corticosteroid injections to treat dactylitis, although conventional disease modifying antirheumatic drugs also are recommended. In this systematic review, the limited data on treatments for dactylitis in PsA highlight the need for a valid, reliable, and responsive clinical outcome measure. Infliximab is the only drug to demonstrate significant improvement of dactylitis during a clinical study.

Cite this document (BETA)

Readership Statistics

7 Readers on Mendeley
by Discipline
 
57% Medicine and Dentistry
 
14% Nursing and Health Professions
 
14% Business, Management and Accounting
by Academic Status
 
43% Other
 
14% Lecturer
 
14% Librarian

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in